Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica C Hassel

Showing results (131-140 of 272) with videos related to

Pageof 28
Sort By:
BMC Urology|July 15, 2015
Primary melanoma of the prostate: case report and review of the literatureGeorgi Tosev, Timur H Kuru, Johannes Huber, et al.
Oncoimmunology|December 24, 2024
The immune checkpoint LAG-3 is expressed by melanoma cells and correlates with clinical progression of the melanomaMelanie Wiecken, Devayani Machiraju, Shounak Chakraborty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 27, 2013
Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52Walter Mier, Clemens Kratochwil, Jessica C Hassel, et al.
Cancers|June 2, 2021
Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free SurvivalTimo E Schank, Andrea Forschner, Michael Max Sachse, et al.
Cancers|December 9, 2023
C-Type Lectin-like Receptor 2 Expression Is Decreased upon Platelet Activation and Is Lower in Most Tumor Entities Compared to Healthy ControlsMani Etemad, Foteini Christodoulou, Stefanie Uhlig, et al.
Cancer Immunology, Immunotherapy : CII|October 12, 2017
Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignanciesKristina Buder-Bakhaya, Karolina Benesova, Carsten Schulz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 26, 2026
Beyond target lesions: Prognostic value of longitudinal AI-derived whole-body [<sup>1</sup>⁸F]FDG PET/CT metrics in metastatic melanomaChristos Sachpekidis, Theodoros P Vagenas, Marilena Müller, et al.
Cancers|March 11, 2023
Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective StudyMartin Salzmann, Alexander Wald, Henner Stege, et al.
Current Biology : CB|September 20, 2005
STAT5 contributes to interferon resistance of melanoma cellsClaudia Wellbrock, Christin Weisser, Jessica C Hassel, et al.
Oncoimmunology|September 17, 2020
Human innate immune cell crosstalk induces melanoma cell senescenceFelix Funck, Jens Pahl, Lenka Kyjacova, et al.
Pageof 28

Showing results (131-140 of 272) with videos related to

Sort By:
Pageof 28
BMC Urology|July 15, 2015
Primary melanoma of the prostate: case report and review of the literatureGeorgi Tosev, Timur H Kuru, Johannes Huber, et al.
Oncoimmunology|December 24, 2024
The immune checkpoint LAG-3 is expressed by melanoma cells and correlates with clinical progression of the melanomaMelanie Wiecken, Devayani Machiraju, Shounak Chakraborty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 27, 2013
Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52Walter Mier, Clemens Kratochwil, Jessica C Hassel, et al.
Cancers|June 2, 2021
Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free SurvivalTimo E Schank, Andrea Forschner, Michael Max Sachse, et al.
Cancers|December 9, 2023
C-Type Lectin-like Receptor 2 Expression Is Decreased upon Platelet Activation and Is Lower in Most Tumor Entities Compared to Healthy ControlsMani Etemad, Foteini Christodoulou, Stefanie Uhlig, et al.
Cancer Immunology, Immunotherapy : CII|October 12, 2017
Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignanciesKristina Buder-Bakhaya, Karolina Benesova, Carsten Schulz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 26, 2026
Beyond target lesions: Prognostic value of longitudinal AI-derived whole-body [<sup>1</sup>⁸F]FDG PET/CT metrics in metastatic melanomaChristos Sachpekidis, Theodoros P Vagenas, Marilena Müller, et al.
Cancers|March 11, 2023
Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective StudyMartin Salzmann, Alexander Wald, Henner Stege, et al.
Current Biology : CB|September 20, 2005
STAT5 contributes to interferon resistance of melanoma cellsClaudia Wellbrock, Christin Weisser, Jessica C Hassel, et al.
Oncoimmunology|September 17, 2020
Human innate immune cell crosstalk induces melanoma cell senescenceFelix Funck, Jens Pahl, Lenka Kyjacova, et al.
Pageof 28